ZyVersa’s inflammasome inhibitor shown to addr
Author: Michael
Tomorrow Bio CEO & Cofounder Emil Kendziorra on
New study finds that up to 124,000 premature dea
Light-based therapy for Parkinson’s disease mo
Company targets US regulatory approval for ‘mi
Ossium Health CEO Kevin Caldwell on reengineerin
Epicore Biosystems CEO on harnessing thousands o
First patients dosed with novel NAD+ precursor d
New £4.
Celebrity-backed proactive health platform wants